https://comparerx.org/news/boehringer-zealand-obesity-trial-disappoints-glp1-buyers CompareRx.org en 2026-10-02T16:15:28.199Z Boehringer obesity drug disappoints in trial — narrowing options for US GLP-1 buyers https://comparerx.org/news/fda-warns-empower-pharmacy-compounded-glp1-telehealth-loophole CompareRx.org en 2026-10-02T12:15:26.512Z FDA warns Empower Pharmacy over mass GLP-1 copies — closing the telehealth loophole https://comparerx.org/news/eloralintide-tirzepatide-diabetes-weight-loss-dropout-rates CompareRx.org en 2026-10-02T08:15:28.799Z Lilly combo drives 23.3% weight loss in diabetes — but 27% dropout rate poses cash-market hurdle https://comparerx.org/news/boehringer-survodutide-synchronize-weight-loss-diabetes-data CompareRx.org en 2026-10-02T04:15:26.225Z Boehringer’s survodutide yields modest 9.8% weight loss — why Phase III dropout rates matter for GLP-1 buyers https://comparerx.org/news/postpartum-glp1-prescriptions-jump-telehealth-buyers CompareRx.org en 2026-10-02T00:15:49.661Z Postpartum GLP-1 prescriptions jump 20-fold — what the surge means for online weight-loss buyers https://comparerx.org/news/glp1-study-detached-fingernails-onycholysis-telehealth-safety CompareRx.org en 2026-10-02T00:15:27.958Z Study links GLP-1 use to fourfold risk of detached fingernails — the new safety data for telehealth buyers https://comparerx.org/news/federal-charges-counterfeit-ozempic-telehealth-safety-crackdown CompareRx.org en 2026-10-01T20:15:28.645Z Feds charge international ring over fake Ozempic — what the crackdown changes for US cash buyers https://comparerx.org/news/pediatric-obesity-kidney-disease-early-glp1-intervention CompareRx.org en 2026-10-01T16:15:29.645Z Pediatric obesity linked to ninefold kidney disease risk — why early GLP-1 care matters https://comparerx.org/news/wegovy-reverses-pediatric-obesity-clinical-data-parents CompareRx.org en 2026-10-01T12:15:24.303Z Wegovy reverses obesity in 40% of kids — what pediatric data changes for cash buyers https://comparerx.org/news/lilly-orforglipron-passes-heart-safety-trial-telehealth-buyers CompareRx.org en 2026-10-01T00:15:27.468Z Lilly’s daily weight-loss pill orforglipron passes key heart safety trial — what it changes for telehealth buyers https://comparerx.org/news/fetal-risk-early-pregnancy-glp1-exposure-telehealth CompareRx.org en 2026-09-30T20:15:29.277Z Two studies find no fetal risk from early GLP-1 exposure — what the clinical reassurance means for telehealth buyers